Antioxidants for Vascular and Muscle Health During Inactivity
Trial Summary
What is the purpose of this trial?
Prolonged periods of reduced activity are associated with decreased vascular function and muscle atrophy. Physical inactivity due to acute hospitalization is also associated with impaired recovery, hospital readmission, and increased mortality. Older adults are a particularly vulnerable population as functional (vascular and skeletal muscle mitochondrial dysfunction) and structural deficits (loss in muscle mass leading to a reduction in strength) are a consequence of the aging process. The combination of inactivity and aging poses an added health threat to these individuals by accelerating the negative impact on vascular and skeletal muscle function and dysfunction. The underlying factors leading to vascular and skeletal muscle dysfunction are unknown, but have been linked to increases in oxidative stress. Additionally, there is a lack of understanding of how vascular function is impacted by inactivity in humans and how these changes are related to skeletal muscle function. It is our goal to investigate the mechanisms that contribute to disuse muscle atrophy and vascular dysfunction in order to diminish their negative impact, and preserve vascular and skeletal muscle function across all the lifespan.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must stop taking dietary supplements 4 weeks before starting the study. If you are on anticoagulant therapy or mitochondrial targeted antioxidants, you cannot participate.
What evidence supports the effectiveness of the treatment MITO-AO, PB-125 for vascular and muscle health during inactivity?
Research shows that mitochondrial-targeted antioxidants can protect muscles from damage during periods of inactivity by reducing harmful molecules called reactive oxygen species (ROS). Similar antioxidants have improved muscle and vascular health in other conditions, suggesting potential benefits for this treatment.12345
Is the antioxidant treatment safe for humans?
How does this antioxidant treatment help with muscle health during inactivity?
This treatment uses a unique approach by targeting mitochondria (the energy-producing parts of cells) with antioxidants to reduce oxidative stress and prevent muscle atrophy (muscle wasting) during periods of inactivity. Unlike other treatments, it specifically addresses the source of reactive oxygen species (ROS) in muscle cells, which are responsible for muscle damage when you're not active.138910
Eligibility Criteria
This trial is for older adults aged 65-85 with good cognitive health (MOCA score ≥26) and normal kidney function. They must not be on a weight-loss diet, have a BMI over 35, or smoke. Those with recent cancer treatment, heavy smoking history, drug/alcohol abuse, or who exercise regularly are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either MITO-AO, PB-125, or placebo during a 5-day bed rest to assess vascular and skeletal muscle function
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- MITO-AO
- PB-125
Find a Clinic Near You
Who Is Running the Clinical Trial?
Joel Trinity
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator